Stockreport

Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF TARRYTOWN, N.Y., April 6, 2020 /PRNewswire/ --Company to Report First Quarter 2020 Results and Host Conference Call and Webcast on May 5, 2020 Regeneron Pharmaceuticals, [Read more]